Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 3,000 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
European Journal of Endocrinology, 2025Proteomic variation underlies the heterogeneous risk of metabolic dysfunction-associated steatotic liver disease for subsequent chronic diseases
Wu J., Wu G., Li J. et al.
Olink Explore 3072/384
Nature Communications, 2025SARS-CoV-2 induced immune perturbations in infants vary with disease severity and differ from adults’ responses
Nehar-Belaid D., Mejías A., Xu Z. et al.
Olink Target 96
Scientific Reports, 2025The contribution of oral infectious diseases in lacunar stroke based on meta-analysis and Mendelian randomization study
Zheng Q., Xu T., Luo S. et al.
Frontiers in Immunology, 2025Investigation of potential protein biomarkers for the screening of placental-mediated fetal growth restriction disorders using targeted proteomics Olink technology
Zhou X., Wang W., Chen L. et al.
Aging Cell, 2025Quercetin Reduces Vascular Senescence and Inflammation in Symptomatic Male but Not Female Coronary Artery Disease Patients
Mury P., Dagher O., Fortier A. et al.
Journal of the American Heart Association, 2025IL1RAP Expression in Human Atherosclerosis: A Target of Novel Antibodies to Reduce Vascular Inflammation and Adhesion
Lindkvist M., Göthlin Eremo A., Paramel G. et al.
Journal of the American Heart Association, 2025Circulating Proteomics Identifies a Dynamic Profile of Hepatic Steatosis During Metabolic Intervention
El‐Sabawi B., Tanriverdi K., Gajjar P. et al.
Journal of the American Heart Association, 2025Systemic Changes in Adults With a Fontan Circulation: Insights From the Plasma Proteome
Kelly B., Ravndal M., Bach P. et al.
The Oncologist, 2025First-in-human phase I open-label study of the anti–TIM-3 monoclonal antibody INCAGN02390 in patients with select advanced or metastatic solid tumors
Gutierrez M., Tang S., Powderly J. et al.
The Oncologist, 2025First-in-human phase I open-label study of the LAG-3 antagonist antibody INCAGN02385 in patients with select advanced or metastatic solid tumors
Powderly J., Gutierrez M., Balmanoukian A. et al.
Nature, 2025Interferon-γ orchestrates leptomeningeal anti-tumour response
Remsik J., Tong X., Kunes R. et al.
Journal of Proteome Research, 2025Dynamic Changes in Lymphocyte Subsets and Inflammation-Immune-Related Proteins in Patients with Thyroid Papillary Carcinoma before and after Radioactive Iodine Therapy
Zhang J., Shi L., Zhang Z. et al.
Scientific Reports, 2025Dissecting immune-mediated pathways in rheumatoid arthritis: A multivariate mediation analysis of antibodies and circulating proteins
Niu J., Zhang P., Liu W. et al.
BMC Neurology, 2025CD28+ CD45RA− CD8br AC mediated the effects of Interleukin- 6 on Alzheimer's disease: A Mendelian Randomization Study
Xu R., Gao Y.
Journal for ImmunoTherapy of Cancer, 2025Combination of a therapeutic cancer vaccine targeting the endogenous retroviral envelope protein ERVMER34-1 with immune-oncology agents facilitates expansion of neoepitope-specific T cells and promotes tumor control
Maldonado M., Gracia-Hernandez M., Le L. et al.
Olink Target 48 Mouse
Blood Journal, 2025Large B-cell lymphoma imprints a dysfunctional immune phenotype that persists years after treatment
Pelzl R., Benintende G., Gsottberger F. et al.
Blood Journal, 2025A Multi-Omics Approach Reveals Novel Regulators of Plasma Factor V Levels: highlight on CLEC4M as a Clearance Receptor
Munsch G., Mohapatra A., van Hylckama Vlieg A. et al.
Europace, 2025From moderate to strenuous training: unraveling mechanistic contributors and biomarkers for atrial fibrillation in exercise
Alcarraz A., Meza-Ramos A., Rubies C. et al.
Olink Target 96 Mouse
Postgraduate Medical Journal, 2025Uncovering novel metabolic and inflammatory pathways in gout using Mendelian randomization
Li Q., Guo R., Wu Z. et al.
Nature Communications, 2025Sex differences in the genetic regulation of the human plasma proteome
Koprulu M., Wheeler E., Kerrison N. et al.
3195 publications
Items per page
441-460 of 3195 publications